Chengheng Liao

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

Nature genetics

Molecular & cellular oncology

University of Texas Southwestern Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Southwestern Medical Center Oct 07 2019

United States

Postdoc :: Pathology

Publications

Chengheng Liao, Lianxin Hu, Yang Zhang
Von Hippel-Lindau protein signalling in clear cell renal cell carcinoma. Nature reviews. Urology (2024)
Xijuan Liu, Jun Wang, Joshua A Boyer, Weida Gong, Shuai Zhao, Ling Xie, Qiong Wu, Cheng Zhang, Kanishk Jain, Yiran Guo, Javier Rodriguez, Mingjie Li, Hidetaka Uryu, Chengheng Liao, Lianxin Hu, Jin Zhou, Xiaobing Shi, Yi-Hsuan Tsai, Qin Yan, Weibo Luo, Xian Chen, Brian D Strahl, Alex von Kriegsheim, Qi Zhang, Gang Greg Wang, Albert S Baldwin, Yang Zhang
Histone H3 proline 16 hydroxylation regulates mammalian gene expression. Nature genetics 54 (11) (2022)
Haibiao Xie, Jin Zhou, Xijuan Liu, Yawei Xu, Austin J Hepperla, Jeremy M Simon, Tao Wang, Hongwei Yao, Chengheng Liao, Albert S Baldwin, Kan Gong, Yang Zhang
USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (36) (2022)
Chengheng Liao, Cherise Ryan Glodowski, Cheng Fan, Juan Liu, Kevin R Mott, Akash Kaushik, Hieu Vu, Jason W Locasale, Samuel K McBrayer, Ralph J DeBerardinis, Charles M Perou, Yang Zhang
Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers. Cancer research 82 (4) (2022)
Rachel Shi, Chengheng Liao, Qing Zhang
Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications. Cells 10 (3) (2021)
Kai Hong, Lianxin Hu, Xijuan Liu, Jeremy M Simon, Travis S Ptacek, Xingnan Zheng, Chengheng Liao, Albert S Baldwin, Yang Zhang
USP37 promotes deubiquitination of HIF2α in kidney cancer. Proceedings of the National Academy of Sciences of the United States of America 117 (23) (2020)
Chengheng Liao, Qing Zhang
BBOX1 promotes triple-negative breast cancer progression by controlling IP3R3 stability. Molecular & cellular oncology 7 (6) (2020)

Chengheng Liao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chengheng Liao